Brenda J. Kitchen - Concepedia

Author

Brenda J. Kitchen

National Cancer Institute

Also Known As

B J Kitchen, B. Kitchen, BRENDA J. KITCHEN, Brenda J. Kitchen, Brenda Kitchen, Not Available Not Available

Publications

706

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health C. S. Mott Children's Hospital Cincinnati Children's Hospital Medical Center Children's Oncology Group

About

Brenda J. Kitchen is an author at National Cancer Institute specializing in medicine, pharmacotherapy, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	82
2	Pharmacology	2	2	49
3	Immunology	1	1	12
4	Pathology	1	1	12
5	Autoimmune Disease	1	1	12

Brenda J. Kitchen

Publications

670

Citations

H-Index

Page 1

	Year	Citations
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease Rebecca Marsh, Lisa Madden, Brenda J. Kitchen, Blood	2010	255
Phase I Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study (ADVL0015) Susan M. Blaney, Mark L. Bernstein, Kathleen Neville, Journal of Clinical Oncology	2004	118
Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group Judith G. Villablanca, Wendy B. London, Arlene Naranjo, Clinical Cancer Research	2011	92
A rapid flow cytometric screening test for X‐linked lymphoproliferative disease due to XIAP deficiency Rebecca Marsh, Joyce Villanueva, Kejian Zhang, Cytometry Part B Clinical Cytometry	2009	65
Cytomegalovirus infection in children with human immunodeficiency virus infection Brenda J. Kitchen, Howard D. Engler, Vee J. Gill, The Pediatric Infectious Disease Journal	1997	31
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101 Peter C. Adamson, Susan M. Blaney, B. C. Widemann, Cancer Chemotherapy and Pharmacology ThrombopoiesisThrombosisGrowth HormoneBlood PlateletPharmacology	2004	30
Thioguanine Administered as a Continuous Intravenous Infusion to Pediatric Patients Is Metabolized to the Novel Metabolite 8-Hydroxy-Thioguanine Brenda J. Kitchen, Asher Moser, Elizabeth Lowe, Journal of Pharmacology and Experimental Therapeutics	1999	27
Cytomegalovirus Ureteritis as a Cause of Renal Failure in a Child Infected with the Human Immunodeficiency Virus Brigitta U. Mueller, Karen Mackay, L B Cheshire, Clinical Infectious Diseases Primary ImmunodeficiencyUrologyMedicineRenal FailureCmv Infection	1995	21
A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. Brenda J. Kitchen, Frank M. Balis, David G. Poplack, PubMed Hematological MalignancyOncologyMedicineHematologyPediatrics	1997	19
Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia Brenda J. Kitchen, Laurence A. Boxer Pediatric Blood & Cancer ImmunologyPathologyPeripheral BloodImmunotherapyAplastic Anemia	2006	12

Page 1